Invention Grant
- Patent Title: Crystalline 4-amino-2-(2,6-dioxopiperidine-3-YL)isoindoline-1,3-dione monohydrate, compositions and methods of use thereof
-
Application No.: US16124013Application Date: 2018-09-06
-
Publication No.: US10590103B2Publication Date: 2020-03-17
- Inventor: Jerry Lee Atwood
- Applicant: Celgene Corporation
- Applicant Address: US NJ Summit
- Assignee: Celgene Corporation
- Current Assignee: Celgene Corporation
- Current Assignee Address: US NJ Summit
- Agency: Jones Day
- Main IPC: C07D401/04
- IPC: C07D401/04 ; A61K31/4035 ; A61K31/45
Abstract:
Provided herein is a crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione monohydrate. Pharmaceutical compositions comprising the crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione monohydrate are also disclosed.
Public/Granted literature
Information query
